🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine the complete response rate when C...
Status
Completed
Location
UPMC Cancer Centers
Start Date
2003-11
Trial ID
NCT00177554
Treatments Being Tested
This phase III trial studies rituximab and yttrium Y-90 ibritumomab tiuxeta...
Status
Terminated
Location
Mayo Clinic in Rochester
Start Date
2015-02-11
Trial ID
NCT02320292
Treatments Being Tested
RATIONALE: Radiolabeled monoclonal antibodies can locate tumor cells and de...
Status
Completed
Location
University of Alabama at Birmingham Comprehensive Cancer Center
Start Date
1999-11
Trial ID
NCT00005592
Treatments Being Tested
RATIONALE: Monoclonal antibodies such as rituximab and yttrium Y 90 ibritum...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2003-02-10
Trial ID
NCT00058422
This randomized phase III trial studies 90-yttrium ibritumomab tiuxetan and...
Status
Terminated
Location
City of Hope Medical Center
Start Date
2015-01
Trial ID
NCT02366663
Primary Objectives: 1. To evaluate the efficacy of Zevalin for the treatme...
Status
Completed
Location
UT MD Anderson Cancer Center
Start Date
2004-02
Trial ID
NCT00387023
RATIONALE: Radiolabeled monoclonal antibodies, such as yttrium Y 90 ibritum...
Status
Completed
Location
Multiple Locations
Start Date
2000-05-16
Trial ID
NCT00562978
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and the safety of a p...
Status
Completed
Location
service d'onco hématologie adultes, hôpital Saint Louis
Start Date
2007-08
Trial ID
NCT00689169
Treatments Being Tested
The goal of this clinical research study is to learn if chemotherapy given ...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2004-06-29
Trial ID
NCT00290511
Treatments Being Tested
The goal of this clinical research study is to see if low intensity chemoth...
Status
Completed
Location
MD Anderson Cancer Center
Start Date
2002-10
Trial ID
NCT00048737